doxycycline Search Results


95
Thermo Fisher doxycycline hydrochloride merck
Doxycycline Hydrochloride Merck, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/pm30792174-190-96-103?v=Thermo+Fisher
Average 95 stars, based on 1 article reviews
doxycycline hydrochloride merck - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

94
Echelon Biosciences intraperitoneal i p injection
Intraperitoneal I P Injection, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/bio_rxiv__64898__2026__04__21__719792-151-6-16?v=Echelon+Biosciences
Average 94 stars, based on 1 article reviews
intraperitoneal i p injection - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Selleck Chemicals doxycycline hyclate
Doxycycline Hyclate, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/bio_rxiv__2024__12__09__627542-253-52-57?v=Selleck+Chemicals
Average 93 stars, based on 1 article reviews
doxycycline hyclate - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

96
Selleck Chemicals doxycycline
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycycline, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/pm36413948-707-12-13?v=Selleck+Chemicals
Average 96 stars, based on 1 article reviews
doxycycline - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Thermo Fisher doxycycline hyclate
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycycline Hyclate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/pm30765726-31-18-20?v=Thermo+Fisher
Average 96 stars, based on 1 article reviews
doxycycline hyclate - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology doxycycline dox
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycycline Dox, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/10__1186_slash_s41016___017___0091___6-46-0-5?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
doxycycline dox - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

dox  (Tocris)
95
Tocris dox
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Dox, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/pmc10723794-135-41-42?v=Tocris
Average 95 stars, based on 1 article reviews
dox - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
LKT Laboratories doxycyclin hyclate
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycyclin Hyclate, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/pmc12340133-64-0-3?v=LKT+Laboratories
Average 93 stars, based on 1 article reviews
doxycyclin hyclate - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Thermo Fisher doxycycline
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycycline, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/bio_rxiv__2025__09__19__677470-187-19-20?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
doxycycline - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Thermo Fisher ac446061000
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Ac446061000, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/bio_rxiv__64898__2026__02__10__704921-155-3-7?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
ac446061000 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

95
Tocris doxycycline hyclate
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycycline Hyclate, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/10__21769_slash_bioprotoc__4913-106-0-2?v=Tocris
Average 95 stars, based on 1 article reviews
doxycycline hyclate - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

91
Toronto Research Chemicals doxycycline d3 hyclate
Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying <t>doxycycline</t> concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.
Doxycycline D3 Hyclate, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxycycline/10__1007_slash_s12161___017___1101___1-28-0-13?v=Toronto+Research+Chemicals
Average 91 stars, based on 1 article reviews
doxycycline d3 hyclate - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

Image Search Results


Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying doxycycline concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.

Journal: Developmental cell

Article Title: Essential role of MESP1-RING1A complex in cardiac differentiation.

doi: 10.1016/j.devcel.2022.10.009

Figure Lengend Snippet: Figure 4. Overexpression of MESP1 variants at days 2 to 4 post hESC differentiation impaired cardiomyocyte differentiation (A) Graph showing the timescale of Dox-induced FLAG-MESP1 overexpression during hESCs cardiac-directed differentiation. Dox was added from days 2 to 4. (B) RT-qPCR from day 30 cardiomyocytes with MESP1 or MESP1 variants (E11D, E104K, or L120P) induced at the cardiac mesoderm stage. Relative expression of MESP1 (at day 4) induced by varying doxycycline concentrations (mg/mL) was shown on the right side. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. (C) Immunostaining and quantification of irregular organized sarcomeric a-ACTININ in day 30 cardiomyocytes with or without MESP1 (WT, E11D, E104K, or L120P) overexpression induced by Dox at the cardiac mesoderm stage. n = 96 (OE MESP1 Dox), n = 38 (OE MESP1 + Dox 0.5 mg/mL, 26-fold overexpression), n = 14 (OE MESP1 E11D Dox), n = 25 (OE MESP1 E11D + Dox 0.5 mg/mL, 40-fold overexpression), n = 27 (OE MESP1 E104K Dox), n = 52 (OE MESP1 E104K + Dox 0.1 mg/mL, 5-fold overexpression), n = 34 (OE MESP1 L120P Dox), and n = 33 (OE MESP1 L120P + Dox 0.2 mg/mL, 17-fold overexpression). Scale bars, 50 mm. ns, p > 0.05, ***p < 0.001 by Fisher’s exact test.

Article Snippet: For FLAG-MESP1 ChIP, cells with Dox-inducible FLAG-MESP1 were treated with 0.03 mg/ml doxycycline (Selleck Chemicals, Houston, TX) during day 3 - day 4 of the cardiomyocyte differentiation process.

Techniques: Over Expression, Quantitative RT-PCR, Expressing, Immunostaining